www.i-canadianpharmacy.com
- US Toll free:
- Regular US:
- UK:
- Categories list
-
- Alcoholism
- Alzheimer's And Parkinson's
- Analgesics
- Anti-inflammatories
- Antiallergic
- Antibiotics
- Anticonvulsants
- Antidepressants
- Antifungals
- Antiparasitic
- Antivirals
- Arthritis
- Asthma
- Birth Control
- Cancer
- Cardiovascular Diseases
- Cholesterol
- Diabetes
- Diuretics
- Erectile Dysfunction
- Eye Care
- Gastrointestinal Tract
- HIV
- Hypertension
- Men's Health
- Mental Disorders
- Migraine
- Muscle Relaxants
- Neurological Disorders
- Obesity
- Osteoporosis
- Respiratory Tract
- Skin Care
- Surgery
- Urinary Tract
- Women's Health
Generic Valsartan - Diovan, Diovan Hct, Aldactone, Micardis
$1.19
Buy now!
Generic Diovan Hct
Valsartan-hydrochlorothiazide 80mg + 12.5/160mg + 12.5mg
Generic Diovan HCT is used for treating high blood pressure.
$1.49
Buy now!
Generic Aldactone
Treating swelling and fluid retention inpatients with congestive heart failure, cirrhosis, or kidney problems (nephrotic...
$0.55
Buy now!
$0.75
Buy now!
Choose Your language:
- Testimonials
-
I received both packets a few weeks ago and I am very pleased with the service. Thank you for the extra 4 samples. When dealing with people so far away, and through the internet, I sometimes wonder if I will even receive anything for my money. I would not hesitate to use your services again or to recommend you to friends. Again, Thank You.
Read more »
- News
-
- FDA approved Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
- Considering the information of three randomized, multicenter, double, blind clinical studies and a retrospective analysis of the medical documentation, FDA approved on October 7, 2011 Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years
- The forming, development and monitoring of the pharmaceutical market in USA in September 2011
- In spite of low rates and stagnation of industrial development, the pharmaceutical market shows a dynamical growth
- Sildenafil citrate and pulmonary arterial hypertension
- Pulmonary arterial hypertension Definition “pulmonary arterial hypertension” is related to a group of diseases characterized by: - Progressive increase in pulmonary vascular resistance; - Reduction in pulmonary bloodflow; - High pulmonary artery pressure; - Contractility of the heart right ventricle; - Right ventricular failure
- Fruit and vegetables do not reduce overall cancer risk, review concludes
- Eating lots of fruit and vegetables will do little to reduce your risk of developing cancer, according to a review of a decade of research involving more than a million people
- Common painkillers could be linked to male reproductive disorder
- The use of mild painkillers, such as paracetamol, in pregnancy – previously considered harmless to the baby in the womb – could be a major factor in the rise of male reproductive disorders, according to a study
-
- Progress report on the first sub-Saharan trial of newer versus older ... - 7thSpace Interactive (press release)
- Progress report on the first sub-Saharan trial of newer versus older
- Novartis: A Sleeper Or A Headache? - Seeking Alpha
- Novartis: A Sleeper Or A Headache?Seeking AlphaThis last quarter, Novartis missed the street estimates mainly because of looming patent expiration of some of their best-selling prescription drugs, most notably Diovan (valsartan)
- Novartis Pressures Generics Makers Over Exforge ANDA - Law360 (subscription)
- Novartis Pressures Generics Makers Over Exforge ANDALaw360 (subscription)
- Novartis expands in generics with $1.53bn Fougera buy - PMLiVE
- Novartis expands in generics with $1
- Auriga Initiates Coverage on Forest Laboratories (FRX); Lack of Near Term ... - StreetInsider.com (subscription)
- Auriga Initiates Coverage on Forest Laboratories (FRX); Lack of Near Term
 |
Bookmark this site |
|---|
 |
Subscribe to the News |
|---|
